Kenneth M Ferguson

Title: Kenneth M Ferguson: Innovator in cGMP-specific Phosphodiesterase Research

Introduction

Kenneth M Ferguson is a notable inventor based in Bothell, WA (US). He has made significant contributions to the field of biochemistry, particularly in the area of cyclic GMP-binding and phosphodiesterase research. With a total of 4 patents, his work has advanced our understanding of enzymatic activity and its modulation.

Latest Patents

Ferguson's latest patents include groundbreaking inventions related to cyclic GMP-binding, specifically the cyclic GMP-specific phosphodiesterase materials. One of his notable patents provides novel purified and isolated nucleotide sequences encoding the cGMP-binding, cGMP-specific phosphodiesterase designated cGB-PDE. This invention also outlines methods and materials for the recombinant production of cGB-PDE polypeptide products, as well as methods for identifying compounds that modulate the enzymatic activity of cGB-PDE polypeptides. Another significant patent focuses on antibodies to the cGMP-binding, cGMP-stimulated phosphodiesterase, further contributing to the understanding of this important enzyme.

Career Highlights

Throughout his career, Kenneth M Ferguson has worked with esteemed institutions such as the University of Washington and Icos Corporation. His research has not only led to valuable patents but has also influenced the scientific community's approach to cyclic GMP-related studies.

Collaborations

Ferguson has collaborated with prominent figures in his field, including Joseph A Beavo and Jackie D Corbin. These partnerships have enriched his research and contributed to the advancement of knowledge in phosphodiesterase activity.

Conclusion

Kenneth M Ferguson's innovative work in the realm of cyclic GMP-specific phosphodiesterase has established him as a key figure in biochemistry. His patents and collaborations reflect a commitment to advancing scientific understanding and developing new methodologies.